αααααβααΎαBOIRF β’ OTCMKTS
add
Boiron SA
35.85$
23 αα»ααΆ, 12:18:23 AM ααααβααα -4 · USD · OTCMKTS · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·α
αα·αααΈαα»α
35.85$
α
ααααααα½αααααΆαα
α»αααααα
32.90$ - 46.22$
ααΎαβαα»αβααΈααααΆα
568.46Β ααΆα EUR
ααα ααα½αααΌαααααα
27.00
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
EPA
ααααααΆαααΈααααΆα
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
(EUR) | αα·αα»ααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌα | 114.17Β ααΆα | -4.81% |
α
αααΆαααααα·ααααα·ααΆα | 77.02Β ααΆα | -4.80% |
α
αααΌααα»ααα | 1.67Β ααΆα | -78.46% |
ααααΆααα
αααααα»ααα | 1.46 | -77.36% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 11.37Β ααΆα | -3.88% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 25.19% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
(EUR) | αα·αα»ααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 53.33Β ααΆα | -77.04% |
ααααααααα»α | 557.65Β ααΆα | -25.92% |
ααΆαααα½ααα»αααααΌαααα»α | 184.68Β ααΆα | -8.91% |
ααΌαβααααα»α | 372.97Β ααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 17.36Β ααΆα | β |
ααααααααααΉαααααα
| 1.67 | β |
ααα
ααααααΎαααααα | 3.06% | β |
ααα
ααααααΎααΎααα»α | 4.40% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
(EUR) | αα·αα»ααΆ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌααα»ααα | 1.67Β ααΆα | -78.46% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 6.77Β ααΆα | -17.50% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -5.09Β ααΆα | 24.82% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -13.23Β ααΆα | -36.19% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -11.36Β ααΆα | -22.93% |
ααα αΌαααΆα
αααααΆααααααα | 5.75Β ααΆα | -7.44% |
α’αααΈ
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it employed a workforce of 2,779 and had a turnover of β¬ 313 million. It is currently a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "Proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
ααΆααααααΎαα‘αΎα
7 αα·αα»ααΆ 1932
αααααβαααααΆα
αα»ααααα·α
2,788